Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study
In real world setting, HRQoL regarding visual function improved in anti-VEGF-treated nAMD patients during the first 12 months after the diagnosis and treatment initiation. Good baseline VA or several comorbidities were associated with decreased overall HRQoL during the follow-up. Despite the effectiveness of anti-VEGF treatment on visual function, several other aspects affecting elderly patients' everyday life should be considered when nAMD treatment is implemented.
Authors
- Nina Hautala (ORCID: https://orcid.org/0000-0001-5454-5602)
- Pasi Ohtonen (ORCID: https://orcid.org/0000-0001-8245-3000)
- Ida Korva-Gurung
- Anna‐Maria Kubin (ORCID: https://orcid.org/0000-0002-8550-7024)
Institutions
- Oulu University Hospital (FI)
- University of Oulu (FI)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1186/s41687-024-00775-z
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Ögonfonden
- Oulun Yliopisto
- Silmäsäätiö